Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Taking a New Approach to Tackle Neurodegenerative Diseases
Home
>
News
>
Taking a New Approach to Tackle Neurodegenerative Diseases
Print
Oligomerix
>
News
>
Taking a New Approach to Tackle Neurodegenerative Diseases
Taking a New Approach to Tackle Neurodegenerative Diseases
Post navigation
Previous Post
Oligomerix Awarded $2.49M from NIH to Further Support Clinical Development of Tau-Targeting Alzheimer’s Disease Therapy Candidate OLX-07010
Next Post
Oligomerix Presents Data from IND-Enabling Studies on Clinical Candidate at Clinical Trials on Alzheimer’s Disease (CTAD) and Neuroscience 2022 Meetings
vera
View posts by vera
Scroll to top
close ×
